The causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic is the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This
Researchers probe intriguing interaction between sugars and the SARS-CoV-2 spike protein
Home ยป
Broadly cross-reactive antibody to SARS-CoV-2 RBD with robust resistance to mutational escape
The current pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has triggered an
New coronavirus variant with E484K mutation detected in Arizona
Arizona joins the ever-growing list of American states harboring a variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
SARS-CoV-2 variants with E484K mutation show mRNA vaccine-induced antibody evasion
A recent study by researchers in Switzerland found that the Pfizer-BioNTech mRNA vaccine had limited efficacy in identifying mutated receptor-binding
What is a protective neutralizing antibody titer against SARS-CoV-2 infection?
Caused by the worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) pandemic continues
What is a protective neutralizing antibody titer against SARS-CoV-2 infection?
Caused by the worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus disease 2019 (COVID-19) pandemic continues
Natural virus-induced immunity protective against UK and South African SARS-CoV-2 variants in hamster study
As new variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to emerge, fueling the continued spread of
Study finds no link between vitamin D and COVID-19 outcomes
New research shows a lack of an association between Vitamin D deficiency and the number of coronavirus disease 2019 (COVID-19)
SARS-CoV-2 can infect blood monocytes and trigger inflammation, finds study
Researchers found about 10% of blood monocytes in coronavirus disease 2019 (COVID-19) patients are infected with severe acute respiratory syndrome
SARS-CoV-2 variants rapidly arise in non-human hosts, potential risk for human reinfection
The coronavirus disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first emerged in December 2019 in Wuhan